Borsa Haberleri
Son finansal haberler · Güncellendi Tem 24, 2026
Boeing hala Max kazasıyla ilgili başı dertte
Boeing is still in hot water over Max crash
The $49.5M verdict is financially immaterial but prolongs the public reckoning around the 737 MAX crises. The real risk is …
Tarihçi: Michael Jackson'ın Thriller'ına Kadar Temettüler Getirilerin %90'ıydı, Sonra Her Şey Değişti
Historian: Dividends Were 90% of Returns Until Michael Jackson’s Thriller, Then Everything Changed
The panel discusses the shift in S&P 500 returns from dividends to price appreciation, with Gemini and Claude disagreeing on …
Bugün, 17 Mayıs 2026, ipotek ve yeniden finansman faiz oranları: Pazartesiden bu yana oranlar çok yükseldi
Mortgage and refinance interest rates today, May 17, 2026: Rates way up since Monday
The panel consensus is that the recent jump in mortgage rates, particularly the inversion of the 5/1 ARM, signals a …
Oklo'nun En Büyük Fırsatı En Büyük Sorunu Olabilir
Oklo's Biggest Opportunity Might Also Be Its Biggest Problem
Oklo's valuation is disconnected from near-term cash flows and heavily reliant on future contracts with hyperscalers. The company faces significant …
Ortalama Amerikalı Geriye Dönüşü Zor Bir Emeklilik Tasarrufu Hatası Yaptı -- Ama İmkansız Değil
The Average American Made a Retirement Savings Mistake It's Hard to Come Back from -- But Not Impossible
The panel consensus is that the article oversimplifies retirement savings, ignoring key factors like sequence-of-returns risk, wage stagnation, and the …
Alibaba Hisse Senedi, Şu Anda Yapay Zeka Boom'unu Oynamanın En Güvenli Yollarından Biri Olabilir
Alibaba Stock May Be One of the Safest Ways to Play the AI Boom Right Now
The panel's net takeaway is that Alibaba's AI pivot is overhyped and priced for stagnation, with significant risks from geopolitical …
Navitas ve Poet: Hangi Yapay Zeka Altyapı Hissesi Daha İyi Bir Alım?
Navitas vs. Poet: Which AI Infrastructure Stock Is the Better Buy?
The panel consensus is bearish on Navitas (NVTS) and Poet (POET), citing high cash-burn rates, dilution risks, and lack of …
AZN :FDA ENHERTU'yu HER2-Pozitif Erken Meme Kanseri İçin Neoadjuvan ve Adjuvan Ayarlarda Onayladı
AZN :FDA Approves ENHERTU For HER2-Positive Early Breast Cancer In Neoadjuvant And Adjuvant Settings
The FDA approval of ENHERTU in neoadjuvant and adjuvant settings expands AstraZeneca's addressable market but faces significant hurdles, including reimbursement …
Citigroup'nun Sessiz Dönüşümü: Hisse Senedi Sonunda Almaya Değer mi?
Citigroup's Quiet Turnaround: Is the Stock Finally Worth Buying?
Panelists are divided on Citigroup's valuation, with some seeing it as a 'finished product' (Gemini, Claude) and others as a …
Bir Merit Medical Systems Yönetim Kurulu Üyesi 5.000 Şirket Hissesi Sattı. Yatırımcılar İçin Ne Anlama Geliyor?
A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?
The panel is divided on MMSI's prospects, with concerns about decelerating growth, tariff exposure, and potential capital allocation risks offsetting …
Emekliler İçin En İyi Yapay Zeka Hissesi (İpucu: Nvidia Değil)
My Top Artificial Intelligence Stock for Retirees (Hint: It's Not Nvidia)
Panelists debate Cisco's (CSCO) transformation into an AI-era infrastructure play, with Gemini highlighting the 'Cisco tax' on enterprise AI and …
iShares EEMA ETF Alınmalı mı? Gateway Wealth Partners Hisselerini 17,5 Milyon Dolar Artırdıktan Sonra
Is the iShares EEMA ETF a Buy After Gateway Wealth Partners Raised Its Stake by $17.5 Million?
The panel is neutral on Gateway's investment in EEMA, with concerns raised about its concentrated exposure to China, Taiwan, and …